Izotropic Corporation
Other OTCRecent
price
P/E
ratio
div
yld
- -
ROIC.AI
Capital Structure
•
in mil. unless spec.Working Capital
•
in mil. unless spec.Growth Rates
•
in mil. unless spec.Quarterly Revenue
•
in mil. unless spec.Quarterly Earnings Per Share
•
in mil. unless spec.Quarterly Dividends Per Share
•
in mil. unless spec.- Similar Companies
- Business
- Izotropic Corporation (Ticker: IZOZF) develops and commercializes advanced medical imaging solutions focused on optical coherence tomography (OCT) technology for vascular and coronary applications. The company offers the iLumen OCT Imaging System, a next-generation platform featuring high-resolution imaging catheters such as the NovaWire OCT Imaging Catheter and related disposable consumables; software for image acquisition, processing, and analysis; and integrated systems for real-time visualization during interventional procedures. Izotropic targets healthcare providers, including interventional cardiologists and vascular specialists, primarily in North America and Europe, with headquarters in Vancouver, British Columbia, Canada, founded in 2012. The company's core products emphasize superior image clarity and penetration depth compared to traditional OCT systems, enabling enhanced detection of plaque characteristics, stent apposition, and vessel dissections. Izotropic operates in the medical device segment of the healthcare industry, with a focus on cardiovascular diagnostics and therapeutics. In recent developments, Izotropic completed a strategic financing round in 2024 to support regulatory submissions and commercial launch preparations for its iLumen platform; announced a distribution partnership with a leading European medical device firm in mid-2025 to expand market access; and initiated first-in-human clinical trials for the NovaWire catheter, marking a key milestone in product validation. These initiatives reflect the company's shift toward global commercialization following FDA 510(k) clearance pursuits and operational scaling in manufacturing capabilities.
Izotropic Executes Formal Agreement with Izotropic Africa for Exclusive Distribution Throughout Africa and the GCC
Izotropic Africa Launches Operations in Casablanca
Izotropic Announces Debt Settlement
Izotropic's "Izotropic Africa" Enters Partnership Discussions with the Mohammed VI Foundation for Science & Health
Izotropic Signs Letter Agreement for Regional Operations in Africa & the GCC
Izotropic Closes Non-Brokered Private Placement and Announces Debt Settlement
Izotropic Provides Corporate Update & Announces Non-Brokered Private Placement
Izotropic (OTCMKTS:IZOZF) Sets New 1-Year High – Here’s What Happened
Izotropic Announces AGM Results
Izotropic (OTCMKTS:IZOZF) Shares Up 4.2% – What’s Next?
Izotropic Launches Podcast Episode #2: AI and the Future of Breast Imaging: How Izotropic is Leading the Innovation
Izotropic Launches "Breast Imaging News" Page on BreastCT.com
NetworkNewsAudio Announces Audio Press Release (APR) on Breast CT Imaging System Capitalizing on Proprietary AI Tech
Izotropic Corporation's (CSE: IZO) (OTCQB: IZOZF) Leverages AI with Next-Gen Breast CT Imaging System
Izotropic CEO Interview: IzoView Differentiators, Regulatory Plans, and Outlook
Izotropic Corporation (CSE: IZO) (OTCQB: IZOZF) Stands Out with Proprietary Next-Gen Breast CT Imaging System
CEO.CA's Inside the Boardroom: This Breast Cancer Tech by Izotropic Targets 50% of Women Currently Underserved
Izotropic Marks Breast Cancer Awareness Month by Highlighting Gaps in Care and the Need for IzoView Breast CT
AI in Breast Imaging: New BreastCT.com Article Examines IzoView's Competitive Edge
Izotropic's IzoView Breast CT the First in Category to Offer Patent-Pending Personalized Radiation Dose